IFNA1 Antikörper
Kurzübersicht für IFNA1 Antikörper (ABIN7251595)
Target
Alle IFNA1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Produktmerkmale
- Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification
-
Immunogen
- Synthetic peptide of human IFNA1/IFNA13
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC 1:30-1:150, ELISA 1:5000-1:10000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.96 mg/mL
-
Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- IFNA1 (Interferon, alpha 1 (IFNA1))
-
Andere Bezeichnung
- IFNA1/IFNA13
-
Hintergrund
- IFNA1 (interferon-alpha) is a member of the Type I IFN (1) family best known for their antiviral activity. It is a key cytokine regulating the activity of B cells,T-helper cells (Th cells),cDCs and natural killer cells (NK cells). Interferon-alpha induces B cell maturation into plasma cells and immunoglobulin production. Interferon-alpha plays an important role in the pathogenesis of systemic lupus erythematosus (SLE). Interferon-alpha was the first cytokine to show clinical benefit in the treatment of certain types of cancer,including melanoma,chronic myelogenous leukemia,and renal cancer.
-
UniProt
- P01562
-
Pathways
- JAK-STAT Signalweg, Hepatitis C
Target
-